Detalhe da pesquisa
1.
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Lancet Oncol
; 25(2): 184-197, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211606
2.
De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort.
Cancer
; 128(9): 1748-1756, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213037
3.
Alloimperatorin activates apoptosis, ferroptosis, and oxeiptosis to inhibit the growth and invasion of breast cancer cells in vitro.
Biochem Cell Biol
; 100(3): 213-222, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263194
4.
Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
Breast Cancer Res Treat
; 196(1): 97-109, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040640
5.
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.
Breast Cancer Res Treat
; 185(2): 371-380, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975708
6.
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial.
Cancer
; 125(13): 2185-2193, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30892700
7.
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Int J Cancer
; 141(1): 129-142, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28294317
8.
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.
Proc Natl Acad Sci U S A
; 111(24): 8838-43, 2014 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876273
9.
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
Breast Cancer Res
; 18(1): 33, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975198
10.
A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.
BMC Cancer
; 16: 606, 2016 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27495967
11.
Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.
BMC Med
; 13: 254, 2015 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26437901
12.
Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Ann Surg Oncol
; 22(4): 1102-10, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249260
13.
Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
Tumour Biol
; 36(9): 6919-27, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854172
14.
Breast cancer in China.
Lancet Oncol
; 15(7): e279-89, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872111
15.
GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Cancer
; 120(9): 1329-37, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477928
16.
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility.
PLoS Genet
; 7(9): e1002259, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21912531
17.
Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer.
Cell Rep Med
; 5(2): 101396, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290515
18.
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial.
Ther Adv Med Oncol
; 16: 17588359231225032, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38362377
19.
Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.
Carcinogenesis
; 34(4): 770-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299407
20.
Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.
Hum Genet
; 132(3): 301-12, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23180271